Clinical Trial Update: CAcTUS - Circulating Tumour DNA Guided Switch [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CAcTUS trial using circulating tumor DNA to guide treatment switching in melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Melanoma | Phase 2 | Status: UNKNOWN